| Current Price | $5.95 | Mkt Cap | $55.0M |
|---|---|---|---|
| Open | $6.02 | P/E Ratio | 0.00 |
| Prev. Close | $5.95 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $5.88 - $6.28 | Volume | 30,307 |
| 52-Wk Range | $4.00 - $24.00 | Avg. Daily Vol. | 131,315 |
A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics.
| Current Price | $5.95 | Mkt Cap | $55.0M |
|---|---|---|---|
| Open | $6.02 | P/E Ratio | 0.00 |
| Prev. Close | $5.95 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $5.88 - $6.28 | Volume | 30,307 |
| 52-Wk Range | $4.00 - $24.00 | Avg. Daily Vol. | 131,315 |
The best Bull and Bear pitches based on recency and number of recommendations.
I'm loathe to pump stocks, especially sketchy biopharmas, but I'd be lying if I said I wasn't excited about the new zzporte position in Palatin. This is a stock I'd given up on following more than a year ago when the demands of parenting had grown to… More
An injectable ED Drug? Yeah I don't think that's going to work.http://www.thestreet.com/story/11171001/2/biotech-stock-mailbag-ranking-cheap-biotechs.html
Read the most recent pitches from players about PTN.
Recs
LPTIM
(< 20)
Submitted: 2/14/2021 8:06:16 PM :
Start Price:
$4.61
NYSE MKT:PTN Score:
+39.25
MOVING UP FOR SURE
TAKE A LOOK
Recs
sk2129
(36.17)
Submitted: 9/17/2015 11:04:53 AM :
Start Price:
$28.00
NYSE MKT:PTN Score:
-151.50
baker bros
Recs
vzuopsref
(< 20)
Submitted: 8/16/2015 8:52:10 AM :
Start Price:
$27.00
NYSE MKT:PTN Score:
-153.29
Pending FDA approval of competitor's similar drug
Find the members with the highest scoring picks in PTN.
007191 (< 20) Score: +274.76
The Score Leader is the player with the highest score across all their picks in PTN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| 007191 | < 20 | 10/18/2006 |
|
1Y | $68.50 | -91.19% | +183.57% | +274.76 | 0 Comment | |
| Perse1 | < 20 | 2/12/2007 |
|
1Y | $56.25 | -89.27% | +170.32% | +259.59 | 0 Comment | |
| jbwest | 87.39 |
|
|
1Y | $47.00 | -87.16% | +170.11% | +257.27 | 0 Comment | |
| allstar31 | 99.93 | 9/15/2014 |
|
5Y | $23.75 | -74.59% | +84.06% | +158.65 | 1 Comment | |
| bbbensphone | 79.27 | 2/29/2016 |
|
5Y | $12.50 | -51.72% | +87.88% | +139.60 | 0 Comment | |
| BravoBevo | 99.97 | 9/1/2022 |
|
5Y | $4.03 | +49.75% | -6.32% | +56.07 | 0 Comment | |
| mn1 | < 20 | 8/31/2022 |
|
5Y | $4.61 | +30.91% | -8.34% | +39.25 | 0 Comment | |
| kfassini | < 20 | 8/31/2022 |
|
5Y | $4.61 | +30.91% | -8.34% | +39.25 | 0 Comment | |
| LPTIM | < 20 | 8/31/2022 |
|
3M | $4.61 | +30.91% | -8.34% | +39.25 | 1 Comment | |
| squidulin | < 20 | 8/31/2022 |
|
5Y | $4.61 | +30.91% | -8.34% | +39.25 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
